Buy Biocon, target Rs 642: Jay Thakkar
Buy Biocon Ltd. at a price target of Rs 642.0 and a stop loss at Rs 606 from entry point.
By ETMarkets.com |
Jay Thakkar of Anand Rathi has a buy call on Biocon with a target price of Rs 642.
The current market price of Biocon is Rs 617.35.
Time period given by the analyst is 'Intra Day' when Biocon price can reach defined target.
Jay Thakkar recommended to keep a stop loss at Rs 606.
Biocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 37,041 Crore) operating in Pharmaceuticals and health care sector.
The company’s top management includes Dr.Arun Chandavarkar, Dr.Jeremy Levin, Dr.Vijay Kuchroo, Mr.Daniel M Bradbury, Mr.John Shaw, Mr.Kiran Mazumdar Shaw, Mr.M Damodaran, Mr.Mary Harney, Mr.Russel Walls, Prof.Ravi Mazumdar.
Company has B S R & Co. LLP as its auditors.
As on 31-12-2017, the company has a total of 600,000,000 shares outstanding.
The current market price of Biocon is Rs 617.35.
Time period given by the analyst is 'Intra Day' when Biocon price can reach defined target.
Jay Thakkar recommended to keep a stop loss at Rs 606.
Biocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 37,041 Crore) operating in Pharmaceuticals and health care sector.
The company’s top management includes Dr.Arun Chandavarkar, Dr.Jeremy Levin, Dr.Vijay Kuchroo, Mr.Daniel M Bradbury, Mr.John Shaw, Mr.Kiran Mazumdar Shaw, Mr.M Damodaran, Mr.Mary Harney, Mr.Russel Walls, Prof.Ravi Mazumdar.
ADVERTISEMENT
Company has B S R & Co. LLP as its auditors.
As on 31-12-2017, the company has a total of 600,000,000 shares outstanding.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
HSBC sees Biocon share price rallying up to Rs 430; stock surges 5%ADVERTISEMENT
